Herpes Zoster Market Players:
- GlaxoSmithKline plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Astellas Pharma Inc.
- Foamix Pharmaceuticals
- GeneOne Life Science
- Merck & Co.
- NAL Pharma
- Novartis AG
- Hoffmann-La Roche Ltd
- TSRL Inc.
- Pfizer Inc.
Besides developing new techniques and medications, global leaders are taking initiatives to grow public awareness about the available solutions, expanding the reach of the herpes zoster market worldwide. The widespread popularity of antiviral drugs is further captivating the focus of pharma giants, willing to solidify their global dominance. This is bringing innovations in this sector, marking steady and potential growth. For instance, in September 2024, GSK partnered with Brooke Shields to spread education about risk and vaccination for shingles by encouraging people aged 50 years or over. As a part of the THRIVE@50+ campaign, the partners aim to promote the effectiveness and importance of available treatments in aging. Such key players include:
